It is associated with a very low risk of progressive liver disease and liver-related mortality
Explored as a possible aid for recovery and lean-mass preservation in frail or catabolic populations, though a Merck-sponsored Phase 2b trial in elderly hip-fracture patients (Adunsky et al., 2011, Archives of Gerontology and Geriatrics, PMID 21067829) was halted early over a cardiac safety signal rather than demonstrating a clear functional benefit
We may notice improved skin texture and tone due to better pigment balance and decreased irritation
A critical mechanism through which the microbiota shapes mucosal immunity is IgA production, the most abundant antibody at mucosal surfaces [43, 44]
This highlights the importance of individualized dosing plans
For a 1.0mg maintenance dose: 1.0 5 = 0.2mL, or 20 units